Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10480893rdf:typepubmed:Citationlld:pubmed
pubmed-article:10480893lifeskim:mentionsumls-concept:C0525013lld:lifeskim
pubmed-article:10480893lifeskim:mentionsumls-concept:C0040624lld:lifeskim
pubmed-article:10480893lifeskim:mentionsumls-concept:C0005221lld:lifeskim
pubmed-article:10480893lifeskim:mentionsumls-concept:C1514873lld:lifeskim
pubmed-article:10480893pubmed:issue38lld:pubmed
pubmed-article:10480893pubmed:dateCreated1999-10-13lld:pubmed
pubmed-article:10480893pubmed:abstractTextFour erythroid-specific DNase I-hypersensitive sites at the 5'-end of the beta-globin locus confer high-level transcription to the beta-globin genes. To identify coactivators that mediate long-range transactivation by this locus control region (LCR), we assessed the influence of E1A, an inhibitor of the CBP/p300 histone acetylase, on LCR function. E1A strongly inhibited transactivation of Agamma- and beta-globin promoters by the HS2, HS2-HS3, and HS1-HS4 subregions of the LCR in human K562 and mouse erythroleukemia cells. Short- and long-range transactivation mediated by the LCR were equally sensitive to E1A. The E1A sensitivity was apparent in transient and stable transfection assays, and E1A inhibited expression of the endogenous gamma-globin genes. Only sites for NF-E2 within HS2 were required for E1A sensitivity in K562 cells, and E1A abolished transactivation mediated by the activation domain of NF-E2. E1A mutants defective in CBP/p300 binding only weakly inhibited HS2-mediated transactivation, whereas a mutant defective in retinoblastoma protein binding strongly inhibited transactivation. Expression of CBP/p300 potentiated HS2-mediated transactivation. Moreover, expression of GAL4-CBP strongly increased transactivation of a reporter containing HS2 with a GAL4 site substituted for the NF-E2 sites. Thus, we propose that a CBP/p300-containing coactivator complex is the E1A-sensitive factor important for LCR function.lld:pubmed
pubmed-article:10480893pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10480893pubmed:languageenglld:pubmed
pubmed-article:10480893pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10480893pubmed:citationSubsetIMlld:pubmed
pubmed-article:10480893pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10480893pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10480893pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10480893pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10480893pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10480893pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10480893pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10480893pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10480893pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10480893pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10480893pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10480893pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10480893pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10480893pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10480893pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10480893pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10480893pubmed:statusMEDLINElld:pubmed
pubmed-article:10480893pubmed:monthSeplld:pubmed
pubmed-article:10480893pubmed:issn0021-9258lld:pubmed
pubmed-article:10480893pubmed:authorpubmed-author:JohnsonKKlld:pubmed
pubmed-article:10480893pubmed:authorpubmed-author:BresnickE HEHlld:pubmed
pubmed-article:10480893pubmed:authorpubmed-author:ZaboikinaT...lld:pubmed
pubmed-article:10480893pubmed:authorpubmed-author:ForsbergE CEClld:pubmed
pubmed-article:10480893pubmed:authorpubmed-author:MosserE AEAlld:pubmed
pubmed-article:10480893pubmed:issnTypePrintlld:pubmed
pubmed-article:10480893pubmed:day17lld:pubmed
pubmed-article:10480893pubmed:volume274lld:pubmed
pubmed-article:10480893pubmed:ownerNLMlld:pubmed
pubmed-article:10480893pubmed:authorsCompleteYlld:pubmed
pubmed-article:10480893pubmed:pagination26850-9lld:pubmed
pubmed-article:10480893pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:10480893pubmed:meshHeadingpubmed-meshheading:10480893...lld:pubmed
pubmed-article:10480893pubmed:meshHeadingpubmed-meshheading:10480893...lld:pubmed
pubmed-article:10480893pubmed:meshHeadingpubmed-meshheading:10480893...lld:pubmed
pubmed-article:10480893pubmed:meshHeadingpubmed-meshheading:10480893...lld:pubmed
pubmed-article:10480893pubmed:meshHeadingpubmed-meshheading:10480893...lld:pubmed
pubmed-article:10480893pubmed:meshHeadingpubmed-meshheading:10480893...lld:pubmed
pubmed-article:10480893pubmed:meshHeadingpubmed-meshheading:10480893...lld:pubmed
pubmed-article:10480893pubmed:meshHeadingpubmed-meshheading:10480893...lld:pubmed
pubmed-article:10480893pubmed:meshHeadingpubmed-meshheading:10480893...lld:pubmed
pubmed-article:10480893pubmed:meshHeadingpubmed-meshheading:10480893...lld:pubmed
pubmed-article:10480893pubmed:meshHeadingpubmed-meshheading:10480893...lld:pubmed
pubmed-article:10480893pubmed:meshHeadingpubmed-meshheading:10480893...lld:pubmed
pubmed-article:10480893pubmed:meshHeadingpubmed-meshheading:10480893...lld:pubmed
pubmed-article:10480893pubmed:meshHeadingpubmed-meshheading:10480893...lld:pubmed
pubmed-article:10480893pubmed:meshHeadingpubmed-meshheading:10480893...lld:pubmed
pubmed-article:10480893pubmed:meshHeadingpubmed-meshheading:10480893...lld:pubmed
pubmed-article:10480893pubmed:meshHeadingpubmed-meshheading:10480893...lld:pubmed
pubmed-article:10480893pubmed:meshHeadingpubmed-meshheading:10480893...lld:pubmed
pubmed-article:10480893pubmed:meshHeadingpubmed-meshheading:10480893...lld:pubmed
pubmed-article:10480893pubmed:meshHeadingpubmed-meshheading:10480893...lld:pubmed
pubmed-article:10480893pubmed:meshHeadingpubmed-meshheading:10480893...lld:pubmed
pubmed-article:10480893pubmed:year1999lld:pubmed
pubmed-article:10480893pubmed:articleTitleRequirement of an E1A-sensitive coactivator for long-range transactivation by the beta-globin locus control region.lld:pubmed
pubmed-article:10480893pubmed:affiliationDepartment of Pharmacology, University of Wisconsin Medical School, Madison, Wisconsin 53706, USA.lld:pubmed
pubmed-article:10480893pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10480893pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:10480893pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10480893lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10480893lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10480893lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10480893lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10480893lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10480893lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10480893lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10480893lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10480893lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10480893lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10480893lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10480893lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10480893lld:pubmed